The Persistence of Silodosin Monotherapy and the Reasons for Withdrawal from Treatment of Previously Untreated Japanese Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia
Table 3
Changes of mean IPSS in patients who continued the silodosin treatment ().
Parameters
0 mos.
3 mos.
6 mos.
12 mos.
18 mos.
24 mos.
30 mos.
36 mos.
42 mos.
48 mos.
Total score
15.2
11.6
(SD)
(6.9)
(7.5)
(7.0)
(7.3)
(7.0)
(7.5)
(6.9)
(8.2)
(8.2)
(7.8)
Storage subscore
7.1
5.4
(SD)
(3.5)
(3.0)
(3.3)
(3.3)
(3.0)
(3.1)
(3.6)
(3.9)
(3.6)
(3.8)
Voiding subscore
6.6
4.0
5.1
4.3
(SD)
(4.1)
(4.0)
(3.8)
(4.0)
(3.9)
(3.9)
(3.7)
(4.2)
(4.1)
(3.9)
QOL index
4.8
(SD)
(0.9)
(1.5)
(1.5)
(1.6)
(1.6)
(1.7)
(1.4)
(1.7)
(1.6)
(1.6)
, , and versus baseline, the paired Student’s -test with Bonferroni correction.